Novel RET Fusion RET-SEPTIN9 Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant Pheochromocytoma. (2021) - Mweempwa, Angela; Xu, Huiling; Vissers, Joseph H. A.; Tothill, Richard W.; Pattison, Andrew D.; Fellowes, Andrew P.; Thomas, David M.; Richardson, Gary; Hicks, Rodney J.; Grimmond, Sean M.; Fox, Stephen B.; Luen, Stephen J.; et al.